Nuo Therapeutics Inc Share Price OTC Bulletin Board
Equities
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
04-19 | Nuo Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
03-19 | Exor-backed NUO invests in Italian teenage clothing chain Subdued | RE |
Sales 2022 | 112K 8.84M | Sales 2023 | 609K 47.9M | Capitalization | 24.33M 1.92B |
---|---|---|---|---|---|
Net income 2022 | -3M -236M | Net income 2023 | -3M -236M | EV / Sales 2022 | 543 x |
Net cash position 2022 | 1.72M 135M | Net cash position 2023 | 673K 52.98M | EV / Sales 2023 | 38.9 x |
P/E ratio 2022 |
-18.9
x | P/E ratio 2023 |
-7.3
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 40.7% |
Managers | Title | Age | Since |
---|---|---|---|
David Jorden
CEO | Chief Executive Officer | 61 | 18/09/08 |
Peter Clausen
COO | Chief Operating Officer | 58 | 31/08/08 |
Members of the board | Title | Age | Since |
---|---|---|---|
C. Winzer
BRD | Director/Board Member | 67 | 29/01/09 |
David Jorden
CEO | Chief Executive Officer | 61 | 18/09/08 |
Paul Mintz
BRD | Director/Board Member | 75 | 06/04/17 |
1st Jan change | Capi. | |
---|---|---|
+9.23% | 114B | |
+11.49% | 104B | |
-13.70% | 22.41B | |
-1.05% | 22.28B | |
-5.29% | 19.07B | |
-38.29% | 18B | |
-3.67% | 17.89B | |
+7.85% | 14.28B | |
+35.11% | 12.55B |